期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 17, 期 5, 页码 271-272出版社
NATURE RESEARCH
DOI: 10.1038/s41571-020-0345-7
关键词
-
类别
资金
- Canada Research Chair in population Cancer Care
The FDA has demonstrated a willingness to expedite access to new cancer medicines by using real-world evidence to support regulatory drug approval. In this article, we explore three recent examples of such approvals and the lessons that can be learned from this collective experience.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据